About this trial
The aim of this study was to determine the effect of cold vapour applied to patients undergoing laparoscopic abdominal surgery primarily on nausea and vomiting and secondarily on antiemetic requirement, patient satisfaction and thirst.
H1: Cold steam application after surgical intervention has a decreasing effect on postoperative nausea.
H2: Cold steam application after surgical intervention has a decreasing effect on postoperative vomiting.
H3: Cold steam application after surgical intervention reduces the need for antiemetic drugs.
H4: Cold steam application after surgical intervention has a satisfactory effect on reducing nausea and vomiting.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergoing abdominal surgery under general anaesthesia,
Admitted to the general surgery ward after surgery,
Who volunteered to participate in the research,
No mental disability,
Disqualifiers
Severe nausea or active vomiting prior to administration,
Migraine, vertigo, etc. who may experience nausea and vomiting due to vestibular disease, pregnancy,
COPD, asthma, etc. with respiratory problems,
Not accepting the application of cold steam,
Trial design
Parallel
Treatments tested in this trial
nebulised distilled water
Other interventionAfter the surgery, the patients will be admitted to the ward and taken to the bed, and their care and treatment will be applied by the nurse. Afterwards, the researcher will apply cold vapour as an inhaler for 15 minutes. For this application, the stand to which the ultrasonic nebuliser device is connected will be positioned close to the patient's bed. 200 ml of distilled water will be placed in the liquid reservoir of the device. The patient will be given a comfortable position and the device will be adjusted so that the steam hose covers the patient's mouth and nose and the patient will be allowed to inhale the steam through the mouth and nose. After the electrical connection of the device is provided, the device will be started and cold steam application will begin. In the 1st hour, inhaler cold water vapour application will be performed for 15 minutes.
Treatment groups
Trial outcomes
Primary outcomes
nausea rate
Nausea rate (%)
Secondary outcomes
Antiemetic requirement
Antiemetic requirement (Yes/No)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: